FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/02/007842 [Registered on: 13/02/2017] Trial Registered Retrospectively
Last Modified On: 08/02/2017
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Screening of retinopathy of prematurity 
Scientific Title of Study   Screening and result analysis of retinopathy of prematurity in premature and low birth weight neonates 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Payal Arora 
Designation  Resident Doctor, Department of Ophthalmology 
Affiliation  government Medical College, Bhavnagar 
Address  Room no. 504, PG2 hostel, Sir Takhtsinhji Hospital campus, Bhavnagar

Bhavnagar
GUJARAT
364001
India 
Phone  07567871995  
Fax    
Email  payal.arora260291@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilesh V Parekh 
Designation  M.S. (ophthalmology) FICO Professor & Head Department of Ophthalmology 
Affiliation  Government Medical College, Bhavnagar 
Address  22, VINAY, Behind Central Salt, Opposite New Filter Tank,

Bhavnagar
GUJARAT
364001
India 
Phone  09428408788  
Fax    
Email  drnvparekh@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nilesh V Parekh 
Designation  M.S. (ophthalmology) FICO Professor & Head Department of Ophthalmology 
Affiliation  Government Medical College, Bhavnagar 
Address  22, VINAY, Behind Central Salt, Opposite New Filter Tank,


GUJARAT
364001
India 
Phone  09428408788  
Fax    
Email  drnvparekh@hotmail.com  
 
Source of Monetary or Material Support  
GOVERNMENT MEDICAL COLLEGE AND SIR TAKHTSINHJI HOSPITAL BHAVNAGAR. 
 
Primary Sponsor  
Name  GOVERNMENT MEDICAL COLLEGE AND SIR TAKHTSINHJI 
Address  DEPARTMENT OF OPHTHALMOLOGY GOVERNMENT MEDICAL COLLEGE AND SIR TAKHTSINHJI HOSPITAL JAIL ROAD BHAVNAGAR 364001 GUJARAT 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
PAYAL ARORA  SIR TAKHTSINHJI HOSPITAL BHAVNAGAR  DEPARTMENT OF OPHTHALMOLOGY GOVERNMENT MEDICAL COLLEGE AND SIR TAKHTSINHJI HOSPITAL, JAIL ROAD BHAVNAGAR 364001 Bhavnagar GUJARAT
Bhavnagar
GUJARAT 
07567871995

payal.arora260291@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
HUMAN ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  PREMATURE AND LOW BIRTH WEIGHT NEONATES,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  1.00 Year(s)
Gender  Both 
Details  Patients whose parents are giving written and
informed consent for examining their child.
New born of gestational age less than 34 weeks or birth weight less than or equal to 2000 g
Any baby of gestational age less than 37 weeks or birth
weight less than or equal to 2000 g with any of following
Sepsis
Acute respiratory distress syndrome
Multiple blood transfusions
Multiple births 
 
ExclusionCriteria 
Details  Parents who are not giving written and informed
consent.
Patient having very poor general condition.
Patient having other congenital anomalies of eye. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Incidence rate will be calculated
in different neonate groups. 
Incidence rate will be calculated
in different neonate groups. According to their gestational age. 36 week of gestational age will be landmark till that screening must be done. 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/11/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
ʉۢ With written and informed consent of the parents

newborn will be examined.

• Detailed history will be taken specially birth weight,

gestational age, any complication during delivery.

• Both the eyes will be examined under torch light for

any gross anterior segment abnormality.

• If direct pupillary reflex is normal then both eyes will

be dilated using diluted Tropicamide(0.4%) +

Phenylephrine(2.5%) eye drops .

• Drops will be instilled three times 10 minutes apart.
While instlling mydriatic eye drop pulse monitor

will be attached to look for pulse and blood

pressure of the child.

• Excess drops immediately blotted to decrease

systemic absorption and side effects.
Retina of both eyes will be examined one by one

using sterile pediatric eye speculum after instilling

1 drop of topical anesthetic eye drop

(paracaine(0.5%)).

• Indirect ophthalmoscopy will be performed using

zeiss indirect ophthalmoscope with 28 D lens.

• All the quadrants of both the eyes will be

examined and charted.
 
Close